Articles tagged with Hiv Research
Comprehensive exploration of living organisms, biological systems, and life processes across all scales from molecules to ecosystems. Encompasses cutting-edge research in biology, genetics, molecular biology, ecology, biochemistry, microbiology, botany, zoology, evolutionary biology, genomics, and biotechnology. Investigates cellular mechanisms, organism development, genetic inheritance, biodiversity conservation, metabolic processes, protein synthesis, DNA sequencing, CRISPR gene editing, stem cell research, and the fundamental principles governing all forms of life on Earth.
Comprehensive medical research, clinical studies, and healthcare sciences focused on disease prevention, diagnosis, and treatment. Encompasses clinical medicine, public health, pharmacology, epidemiology, medical specialties, disease mechanisms, therapeutic interventions, healthcare innovation, precision medicine, telemedicine, medical devices, drug development, clinical trials, patient care, mental health, nutrition science, health policy, and the application of medical science to improve human health, wellbeing, and quality of life across diverse populations.
Comprehensive investigation of human society, behavior, relationships, and social structures through systematic research and analysis. Encompasses psychology, sociology, anthropology, economics, political science, linguistics, education, demography, communications, and social research methodologies. Examines human cognition, social interactions, cultural phenomena, economic systems, political institutions, language and communication, educational processes, population dynamics, and the complex social, cultural, economic, and political forces shaping human societies, communities, and civilizations throughout history and across the contemporary world.
Fundamental study of the non-living natural world, matter, energy, and physical phenomena governing the universe. Encompasses physics, chemistry, earth sciences, atmospheric sciences, oceanography, materials science, and the investigation of physical laws, chemical reactions, geological processes, climate systems, and planetary dynamics. Explores everything from subatomic particles and quantum mechanics to planetary systems and cosmic phenomena, including energy transformations, molecular interactions, elemental properties, weather patterns, tectonic activity, and the fundamental forces and principles underlying the physical nature of reality.
Practical application of scientific knowledge and engineering principles to solve real-world problems and develop innovative technologies. Encompasses all engineering disciplines, technology development, computer science, artificial intelligence, environmental sciences, agriculture, materials applications, energy systems, and industrial innovation. Bridges theoretical research with tangible solutions for infrastructure, manufacturing, computing, communications, transportation, construction, sustainable development, and emerging technologies that advance human capabilities, improve quality of life, and address societal challenges through scientific innovation and technological progress.
Study of the practice, culture, infrastructure, and social dimensions of science itself. Addresses how science is conducted, organized, communicated, and integrated into society. Encompasses research funding mechanisms, scientific publishing systems, peer review processes, academic ethics, science policy, research institutions, scientific collaboration networks, science education, career development, research programs, scientific methods, science communication, and the sociology of scientific discovery. Examines the human, institutional, and cultural aspects of scientific enterprise, knowledge production, and the translation of research into societal benefit.
Comprehensive study of the universe beyond Earth, encompassing celestial objects, cosmic phenomena, and space exploration. Includes astronomy, astrophysics, planetary science, cosmology, space physics, astrobiology, and space technology. Investigates stars, galaxies, planets, moons, asteroids, comets, black holes, nebulae, exoplanets, dark matter, dark energy, cosmic microwave background, stellar evolution, planetary formation, space weather, solar system dynamics, the search for extraterrestrial life, and humanity's efforts to explore, understand, and unlock the mysteries of the cosmos through observation, theory, and space missions.
Comprehensive examination of tools, techniques, methodologies, and approaches used across scientific disciplines to conduct research, collect data, and analyze results. Encompasses experimental procedures, analytical methods, measurement techniques, instrumentation, imaging technologies, spectroscopic methods, laboratory protocols, observational studies, statistical analysis, computational methods, data visualization, quality control, and methodological innovations. Addresses the practical techniques and theoretical frameworks enabling scientists to investigate phenomena, test hypotheses, gather evidence, ensure reproducibility, and generate reliable knowledge through systematic, rigorous investigation across all areas of scientific inquiry.
Study of abstract structures, patterns, quantities, relationships, and logical reasoning through pure and applied mathematical disciplines. Encompasses algebra, calculus, geometry, topology, number theory, analysis, discrete mathematics, mathematical logic, set theory, probability, statistics, and computational mathematics. Investigates mathematical structures, theorems, proofs, algorithms, functions, equations, and the rigorous logical frameworks underlying quantitative reasoning. Provides the foundational language and tools for all scientific fields, enabling precise description of natural phenomena, modeling of complex systems, and the development of technologies across physics, engineering, computer science, economics, and all quantitative sciences.
A 20-year Quebec study reveals socio-economic inequalities impact access to AIDS treatment, with HIV-infected individuals on social assistance struggling to initiate early ART. The study highlights the need to consider socio-economic factors in controlling the HIV epidemic, as delayed access can put patients' health at risk.
Scientists at the University of Waterloo have developed a vaginal implant that decreases the number of cells targeted by the HIV virus, taking advantage of natural immunity. The implant, containing hydroxychloroquine, was tested in an animal model and showed significant reduction in T cell activation.
The US government has renewed funding for UC San Diego's Center for AIDS Research, supporting continued studies of HIV/AIDS. The five-year, $15 million grant will focus on finding a cure for HIV in those already infected and preventing transmission to uninfected individuals.
Two genetically modified broadly neutralizing antibodies protected rhesus macaques from an HIV-like virus, SHIV, with long-term protection of up to 37 weeks. The study demonstrated that genetic mutations increased durability and led to extended protection.
Researchers found an association between certain risk-related terms on Google Trends and subsequent syphilis trends reported to the CDC. The Twitter-based model predicted state-level trends in syphilis with 90% accuracy, allowing for early warning systems to be developed.
A recent study found that a focus on boys and young men is crucial to continue progress in reducing new HIV infections. Researchers suggest that improved health counseling and engagement with peers can encourage more adolescents to undergo circumcision, which reduces the risk of HIV transmission by 60%. The study also highlights the ne...
Artificial molecules mimicking DNA's surface features have been successfully synthesized, demonstrating the ability to inhibit activity of several DNA-binding enzymes. These findings pave the way for new medicines by inhibiting DNA-protein interactions.
Researchers at Ohio State University discovered a pathway that involves enzyme SAMHD1 in regulating the immune system. This study suggests blocking SAMHD1 activity might thwart disease progression and provides potential targets for new treatments.
Three NIDA Avant-Garde Award recipients will receive funding to investigate natural killer cell targeting, therapeutic dendritic cell vaccines, and a new platform for HIV-1 vaccine development. These innovative approaches aim to enhance the immune response against HIV in drug users.
Researchers at UC Davis have discovered a potential strategy to combat HIV latency by modulating histone crotonylation, which regulates HIV transcription. Increasing crotonylation increased viral transcription in both cell models and patient samples, suggesting a promising approach for developing an HIV cure.
The HOPE open-label study found that women's risk of acquiring HIV was reduced by more than half, with an incidence rate of 1.9 new infections per 100 participants. Women's adherence to the ring use appears to be higher in HOPE compared to ASPIRE, with 89% indicating regular use.
A new study found that genital inflammation significantly reduces the effectiveness of tenofovir gel in preventing HIV infection in women. The study showed that tenofovir gel provided only 57% protection against HIV acquisition in women with genital inflammation, even if they used the gel consistently.
Researchers at the University of Illinois Chicago are investigating whether menstrual cup use reduces bacterial vaginosis and sexually transmitted infections in girls in Kenya. Studies have shown that menstrual cups can significantly reduce these infections by up to 52%.
A recent study has confirmed that the spleen acts as an HIV sanctuary, hiding the virus from detection even when antiretroviral therapy is effective. Researchers also explore natural products with therapeutic compounds and gather insights on people living with HIV's perceptions of cure-related research.
A recent study found a strong association between high levels of alpha-4 beta-7 on CD4+ T cells and increased risk of HIV acquisition and rapid disease progression. Women with higher pre-infection levels of alpha-4 beta-7 had more rapidly declining CD4+ T cell counts and greater viral loads.
A recent study found that latent HIV reservoirs exhibit inherent resistance to CD8+ T-cells, making it challenging to eliminate the virus. Researchers at George Washington University used their most powerful combinations against these cells, but were unable to kill the virus, which remained present at high levels.
A new study published in LGBT Health found that young men who have sex with men are less likely to receive school-based HIV education than their female-only sex partners. The study associated HIV education with reduced sexual risk behaviors, particularly among young MSM.
Researchers found that conducting HIV testing among social and risk networks of those recently diagnosed with HIV can identify undiagnosed cases at higher rates and lower costs than other approaches. The study used a network-based recruiting, counseling, and HIV testing strategy, which was more effective in locating undiagnosed positives.
Timothy Ray Brown, the first person cured of HIV, continues to advocate for research funding and education on the impact of an HIV cure. Despite disappointment over decreased public desire for a cure, he remains optimistic that a functional cure can be achieved with proper funding.
A new study published in PLOS Medicine provides a more accurate representation of site- and regional-level mortality among people on HIV therapy in Zambia. The research found that mortality is substantially underreported in routine provincial program data, leading to a change in the ranking of provinces by mortality rates.
A new study provides a model for accurately measuring HIV mortality rates in Zambia, which is crucial for improving treatment outcomes. The study found that mortality is substantially underreported in routine data, with some provinces showing mortality rates up to 23-fold higher than reported.
Researchers at MIT and Brigham and Women's Hospital have developed a capsule that can deliver a week's worth of HIV drugs in a single dose. The new design allows for gradual release of the drug throughout the week, improving patient adherence and potentially preventing infections by up to 20 percent.
Researchers at Brigham and Women's Hospital have developed a slow-release pill that can deliver HIV therapeutics once weekly, improving adherence rates and preventing thousands of new infections. The pill uses an ingestible mini pill box to release medication slowly over time, reducing the need for daily doses.
Researchers developed a long-acting compound that targets HIV's replication, suppressing the virus and protecting immune cells. The compound works synergistically with current treatments, enhancing their potency and potentially improving treatment for 37 million people worldwide affected by HIV.
Research suggests that the DMPA contraceptive shot increases the risk of HIV infection by 40% due to its effects on immune function and genital tract barrier function. Alternative hormonal contraceptives with a different form of progestin may help reduce this risk.
Researchers found that FDA-approved anti-inflammatory medications tofacitinib and ruxolitinib can block HIV production from infected cells, prevent transmission to bystander cells, and decay the viral reservoir. The study suggests using Jak inhibitors as a potential treatment for HIV-infected individuals to control the virus.
A new population-based model has been developed to track new HIV infections with greater accuracy, enabling researchers to better target prevention strategies and evaluate interventions. The tool uses biomarkers to identify recent infections, reducing false classifications and costs for studies.
Scientists at The Ottawa Hospital and University of Ottawa discover Maraba virus can eliminate latent HIV-infected cells. Laboratory tests show the virus targets cells with impaired interferon pathway, leaving healthy cells unharmed.
Researchers developed an experimental heroin vaccine that induces antibodies blocking the drug's effects, preventing euphoria and addictive properties. The vaccine appears to dampen the impact of heroin at high doses, potentially preventing overdose. Antibodies induced by the vaccine do not cross-react with therapies for opioid misuse.
Researchers identified Nef MY9 and Pol IY11 as immunodominant epitopes for HLA-C*12:02 haplotype, showing its ability to supplement HLA-B's control over HIV-1 replication in infected individuals. The study adds knowledge to the AIDS research puzzle, highlighting a potential protective mechanism against the virus.
A KAIST research team developed a new technology to detect RNase H activity using catalytic hairpin assembly, overcoming limitations of existing methods. The technology amplifies detection signals, enabling more sensitive assays and potential screening for inhibitors.
A randomized clinical trial found no benefit for a therapeutic HIV vaccine in suppressing viral infection, but provided valuable insights for future cure efforts. Four people in the placebo group exhibited spontaneous HIV suppression, exceeding expected rates among the general population.
Researchers at Boston Children's Hospital are developing new models to test HIV vaccines, enabling the rapid evolution of human antibodies in mice. This approach could lead to a protective version of broadly-neutralizing antibodies in uninfected individuals through preventative immunization.
A phase 2b clinical trial of a novel HIV vaccine regimen has begun in southern Africa, aiming to reduce the incidence of HIV infection. The mosaic vaccine, developed by researchers at the Ragon Institute, is designed to respond to various viral strains and address genetic diversity.
The first large-scale clinical trial of a long-acting injectable medication for HIV prevention in sexually active women has begun. The study will examine whether a long-acting form of the investigational anti-HIV drug cabotegravir can safely protect women at risk for HIV infection.
The HPTN 084 study enrolls 3,200 HIV-uninfected women in seven countries to test the safety and efficacy of a long-acting injectable cabotegravir compared to daily oral TDF/FTC. The study aims to increase HIV prevention choices for women, particularly in sub-Saharan Africa where they bear a disproportionate burden.
The NIH has launched a Phase 2b proof-of-concept study called Imbokodo to assess the safety and efficacy of an experimental HIV vaccine regimen. The study aims to enroll 2,600 HIV-negative women in sub-Saharan Africa and will test the quadrivalent mosaic vaccine against placebo.
A new dual-purpose drug delivery device, SCHIELD, aims to provide long-acting contraception and HIV prevention for women in low- and middle-income countries. The device, set to be launched in Kenya and South Africa, has the potential to improve health outcomes and empower women.
Researchers at Stellenbosch University found that HIV affects the brain in early stages of infection, leading to decreased blood flow and brain functional impairment. The study used fMRI scans to compare brain activity of people with and without HIV, revealing a link between frontal lobe atrophy and cognitive symptoms.
A combination of proven HIV prevention measures significantly reduced new HIV infections in a Ugandan district. The strategy includes voluntary medical male circumcision and HIV-suppressing antiretroviral therapy.
A study published in PLOS Medicine found that starting antiretroviral therapy (ART) immediately following an HIV diagnosis dramatically improves retention in clinical HIV care. Patients who were eligible for ART at diagnosis were 25 percentage points more likely to start therapy and 18 percentage points more likely to remain in care at...
Researchers have designed second-generation vaginal films that can provide extended release and improve mucoadhesiveness for up to seven days, addressing issues with current HIV prevention methods. These films use a combination of modified natural polymer and functional biopolymer to deliver antiretroviral drugs.
Researchers find that certain spellings in HIV and other viruses' genetic codes are critical for replication and infection. The discovery highlights a potential avenue for vaccine development by exploiting this variation.
Researchers at OHSU have successfully performed stem transplants on monkeys, offering a critical tool to explore the Berlin patient's unexpected cure. The findings provide hope for improving stem cell transplant outcomes for human patients with blood-related conditions.
A special issue of PLOS Medicine presents groundbreaking research on HIV prevention, treatment, and cure. Studies reveal improved outcomes with combined interventions aimed at linking patients to care and retention, as well as substantial benefits for people with HIV.
Women involved in high-risk sex behaviors have more diverse vaginal bacterial microbiota, a lower abundance of protective Lactobacillus bacteria, and are at higher risk for STIs and HIV-1 acquisition. The study suggests that low diversity vaginal microbiota is associated with less risk of vaginal infections.
A comprehensive review by Australian researchers found that 15.6 million people have recently injected drugs, with 18% living with HIV infection and 52% testing positive for hepatitis C antibody. The authors highlight the need to scale up interventions for people who inject drugs to prevent the spread of blood-borne viruses.
Researchers identify regulatory T cells containing replication-competent virus in lymph nodes and gut, providing a strong rationale for targeting CTLA4. The discovery could help design immunotherapies to purge the viral reservoir and induce a stronger antiviral immune response.
A GW School of Medicine researcher is leading a five-year study on how cocaine affects HIV replication and transcription. The goal is to identify biomarkers for cocaine use and develop therapeutics for cocaine-using HIV-infected individuals.
Researchers have developed a synthetic molecule, SUW133, that awakens dormant HIV cells and then knocks them out. The technique, called 'kick and kill,' could lower the viral reservoir enough for people with HIV to discontinue their anti-viral therapy.
The National Institute on Drug Abuse has awarded UCLA a $5 million grant to create a resource center for researchers studying the effects of substance abuse on HIV/AIDS. The Collaborating Consortium of Cohorts Producing NIDA Opportunities will connect researchers with access to millions of pieces of research data and lab samples.
Researchers will systematically identify resources that successful patients use to overcome HIV challenges, developing a novel public health measure called resilience. The goal is to design interventions to increase suppressed HIV viral load among patients.
A new synthetic molecule, SUW133, has been designed to reactivate dormant human immunodeficiency virus (HIV) in mice and lead to cell death. In a study published in PLOS Pathogens, researchers found that up to 25% of latently infected cells died within 24 hours after treatment.
Scientists at NIH and Sanofi created a trispecific antibody that protects monkeys from two strains of SHIV, a monkey form of HIV. The antibody stops more strains from infecting cells than individual natural antibodies, showing promise for long-acting prevention and treatment.
A team of researchers at the University of Montreal Hospital Research Centre has discovered a molecule that stimulates HIV replication in CD4 T cells located in the gut. They have also started testing medications to block this replication and decrease inflammation of the intestinal mucosa, which could lead to a functional cure for HIV.
Researchers at the University of Montreal Hospital Research Centre have discovered a molecule that stimulates HIV replication in CD4 T cells located in the gut. By targeting this molecule, medications can significantly reduce HIV replication in undetectable patients, potentially leading to a functional cure.
A Yale-developed videogame improved sexual health knowledge and attitudes among minority youth, while also reducing risky behavior and STI transmission rates. The game, PlayForward: Elm City Stories, was designed with teen input and showed sustained positive changes in attitudes and knowledge over a year.
Researchers identified glycans as a critical anchor for antibodies that can broadly neutralize the virus, suggesting vaccines targeting this region may elicit effective protection. The discovery could speed efforts to develop a successful HIV vaccine.
The Joint West Africa Research Group (JWARG) has begun a study to identify cases of suspected severe infectious diseases in West Africa. The study will enroll adult volunteers who present as severely ill with a suspected infectious source, and collect samples for laboratory analysis.
Assistant Professor Julien van Grevenynghe at INRS-Institut Armand-Frappier Research Centre has received a $25,000 award to further his research on autophagy in HIV infection. The Banting Research Foundation recognizes the potential of his work to strengthen the immune system and develop effective HIV vaccines.